Keywords: salix, submits, balsalazide, nda, fda, nasdaq-listed, pharmaceuticals

Salix submits balsalazide NDA to FDA

Article | 23 July 2007

Print This

Nasdaq-listed Salix Pharmaceuticals says it has submitted a New Drug Application to the US Food and Drug Administration seeking approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in